Europe Accelerates Review of The COVID-19 Vaccine From Pfizer

Europe Accelerates Review of The COVID-19 Vaccine From Pfizer
SHARE

Europe is devastated by the COVID-19 pandemic, as countries like France, the UK, Russia, or Spain are facing the highest numbers ever recorded of daily infections. Pfizer developed a vaccine that was already approved in the US, and things are going a bit slower in the old continent.

Wsj.com writes that governments have started to induce pressure on authorities for approving the vaccine from Pfizer, and the chief drug regulator of the European Union will accelerate the review of the drug.

Vaccinations in Europe could start before Christmas

The vaccination with the drug developed by Pfizer could begin in some countries before Christmas if the full approval occurs shortly. There are a lot of skeptics out there who do not trust COVID-19 vaccination, and we can’t pretend that they don’t exist. Therefore, a careful review was needed precisely to ensure public confidence in the long-awaited vaccine.

The Austrian Chancellor Sebastian Kurz declared:

I hope that the EU too will get quick and unbureaucratic approval of the first vaccines while observing all scientific standards,

He also added:

The earlier we in the EU are able to start vaccinating, the better. Because every day of the pandemic in Europe means thousands of deaths, severe economic damage and innumerable people who must fear for their jobs.

Polish Prime Minister Mateusz Morawiecki announces that some non-EU Western and Asian countries have already started to vaccinate their citizens.

Whether we like it or not, Christmas and The New Year are representing health risks for many people. That’s why Germany, Austria, Poland, and other European countries are asking their citizens to stay at home during the Holidays. These countries had also restricted church services and gatherings of people.


SHARE

Share this post

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.